Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2020

Oct 8, 2020

30229_dirs_2020-10-08_24b13bfc-7aad-45d4-ad2b-4a0faab161a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2020-10-06

Reporting Person: Carestio Daniel A (Sr VP and Chief Operating Off)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-06 Ordinary Shares M 13500 $77.07 Acquired 39814 Direct
2020-10-06 Ordinary Shares S 3664 $180.65 Disposed 36150 Direct
2020-10-06 Ordinary Shares S 2903 $181.25 Disposed 33247 Direct
2020-10-06 Ordinary Shares S 3444 $182.86 Disposed 29803 Direct
2020-10-06 Ordinary Shares S 2777 $183.67 Disposed 27026 Direct
2020-10-06 Ordinary Shares S 712 $184.53 Disposed 26314 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-10-06 Employee Stock Option (right to buy) $77.07 M 13500 Acquired 2027-05-30 Ordinary Shares (13500) Direct

Footnotes

F1: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024.

F2: This exercise of stock options and sale of a total of 3,664 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F3: Price reflects a weighted average sale price for multiple transactions ranging from $180.00 to $180.9850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: This exercise of stock options and sale of a total of 2,903 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F5: Price reflects a weighted average sale price for multiple transactions ranging from $181.0050 to $181.8150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6: This exercise of stock options and sale of a total of 3,444 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F7: Price reflects a weighted average sale price for multiple transactions ranging from $182.2150 to $183.19 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: This exercise of stock options and sale of a total of 2,777 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F9: Price reflects a weighted average sale price for multiple transactions ranging from $183.25 to $184.2450 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F10: This exercise of stock options and sale of a total of 712 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F11: Price reflects a weighted average sale price for multiple transactions ranging from $184.30 to $184.85 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F12: This option to purchase 18,000 STERIS ordinary shares, of which 13,500 are fully vested and were exercised, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 18,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.